Since this could provide useful therapeutic approaches against COVID-19 (coronavirus disease 2019), we investigated the mutational landscape of the Spike RBD with the ACE2 host–cell receptor or different antibodies displayed over the ferritin nanocages. This evidence concerns the gene CHMP5 and COVID-19.